Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1196

Wireless Monitoring in Home Healthcare

Wireless Monitoring in Home Healthcare

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $1,850.00
Meta Description No
Publisher Berg Insight
Date of Report Jun 20, 2011
Quick Overview
This price is subject to Pdf 1-5 users

This report will allow you to:

Understand the dynamics of the health monitoring market in Europe and North America.

Comprehend how the use of wireless technology could improve the monitoring of cardiac activity, blood pressure, glucose levels and lipid levels.

Evaluate the business opportunities for mobile industry players in home healthcare.

Identify key players on the health monitoring market.

Predict future market and technology developments.


Executive summary
The market for home wireless monitoring in healthcare is still nascent, but rapidly evolving.
Among the most common conditions to monitor at home are irregular heartbeats or cardiac
arrhythmia, high blood pressure, the glucose levels in diabetes, and high levels of lipids or
fats in the blood. In Europe and North America 40 million people have cardiac arrhythmia,
200 million people have high blood pressure, 60 million people are diabetic, and 180 million
people have severe elevation of blood lipids. All these diseases are increasing as a result of
people getting older and heavier, and all are major causes of high healthcare costs. Today,
there exists equipment allowing home monitoring of all the conditions. Almost all new devices
are digital, and there is a strong tendency towards data transfer capability and wireless
features. While many companies are making efforts towards developing specialised PDAs
coupled to each monitor, Berg Insight believes that other devices as mobile phones and
computers will be used, and that data will be collected in central server systems, allowing
location-independent access. Furthermore, Internet based health portals will drive the
development. Berg Insight expects data monitoring and distance disease management to
become the key parts of tomorrow’s healthcare system.
The market for wireless monitoring solutions for home medical care is still in a very early
stage. There are just a few products available on the market and compared to other sectors,
the healthcare industry is late to adopt wireless technologies. The few commercial systems
that do exist primarily use fixed line communication. This means that there is a significant
untapped potential in the market. Berg Insight estimates that 250 million people in the EU and
the US suffer from one or several diseases that may require home monitoring. Although not
everyone benefits from regular home monitoring, there will probably be 50 million people for
whom wireless solutions available would be beneficial. Additionally, there are those
monitoring their health without a strict medical need, further adding to the potential. However
one must be very cautious regarding how fast it will evolve due to the intrinsic barriers in the
healthcare industry, which is thoroughly regulated and generally operates under difficult
financial conditions. Currently remote monitoring has only given rise to a substantial market in
cardiac monitoring.
The global market for cardiac monitoring is worth less than US$ 300 million, mainly in the US.
There is currently an ongoing shift in technology from primitive transtelephonic transfer to
modern means of communication. The market is dominated by CardioNet, CardGuard and
Raytel Cardiac Services, but there are also several upstart companies such as Transoma
offering interesting alternatives, as well as established medical device manufacturers such as
Medtronic. The blood pressure monitoring world market is worth about US$ 800 million, with
a growth rate of 9 percent, and dominated by Omron, with Microlife and A&D Medical as
runners up. The adoption of wireless solutions is still in its infancy in this segment. The world
glucose level monitoring market is worth US$ 8.9 billion, and is growing at a rate of 11
percent annually. Roche, Johnson & Johnson, Abbott and Bayer together hold 90 percent of
the market. Abbott recently became the first of the major companies to offer continuous
glucose monitoring. The global lipid monitoring market is worth approximately US$ 100
million and is growing by 7 percent annually. Biomedix and CardioChek are the market
leaders.
Recently, a range of IT and telecom companies, such as France Telecom, Deutche Telekom
and Alcaltel-Lucent have released healthcare related products, and Qualomm even plans to
start a health-oriented MVNO, Lifecomm. Also, many handset manufacturers have shown a
clear interest in health-related applications, and some, like LG, have even integrated medical
monitors in certain models. Furthermore the IT giants Google and Microsoft have recently
released health portals, where users can gather and analyse medical data.
Table of Contents
Table of Contents

1 The challenge from welfare diseases ..................................................................................3
1.1 Introduction..................................................................................................................3
1.2 Common chronic welfare diseases .............................................................................4
1.2.1 Cardiac arrhythmia................................................................................................4
1.2.2 Hypertension .........................................................................................................7
1.2.3 Diabetes ................................................................................................................7
1.2.4 Hyperlipidemia ......................................................................................................8
1.3 Healthcare providers and reimbursement systems by market ...................................9
1.3.1 Healthcare in Europe ..........................................................................................12
1.3.2 Healthcare in the US and Canada ......................................................................13
1.3.3 Healthcare in Asia and Australia .........................................................................14
2 Home healthcare monitoring.............................................................................................17
2.1 Cardiac monitoring ....................................................................................................17
2.2 Blood pressure monitoring........................................................................................20
2.3 Glucose monitoring ...................................................................................................21
2.4 Lipid monitoring.........................................................................................................24
2.5 Technology trends in health monitoring....................................................................25
2.5.1 Going digital, going wireless...............................................................................25
2.5.2 Dedicated PDAs vs general devices ...................................................................27
2.5.3 Outsourcing of health monitoring .......................................................................30
2.5.4 Distance disease management...........................................................................31
2.5.5 Frequency and volume of data to transfer..........................................................32
2.5.6 eHealth and telemedicine ...................................................................................33
2.6 Regulatory environment ............................................................................................ 34
2.6.1 Regulatory environment in Europe .....................................................................34
2.6.2 2.6.3 2.6.4 Regulatory environment in the US ......................................................................35 Regulatory environment on other major markets ...............................................37 International standardization...............................................................................37
3 Healthcare monitoring solution providers .........................................................................39 3.1 Cardiac monitoring vendors ......................................................................................40 3.1.1 CardioNet ............................................................................................................40
3.1.2 Card Guard..........................................................................................................42
3.1.3 Philips Healthcare and Raytel Cardiac Services.................................................44 3.1.4 Aerotel .................................................................................................................44
3.1.5 Kiwok...................................................................................................................45
3.1.6 Medtronic ............................................................................................................45
3.1.7 SHL Telemedicine ...............................................................................................46
3.1.8 Transoma Medical...............................................................................................47
3.1.9 T Z Medical..........................................................................................................49
3.2 Blood pressure monitoring vendors..........................................................................49 3.2.1 Omron Healthcare...............................................................................................49
3.2.2 A&D Medical........................................................................................................50
3.2.3 AViTA ...................................................................................................................51
3.2.4 Honeywell Hommed............................................................................................51 3.2.5 HoMedics ............................................................................................................51
3.2.6 IEM ......................................................................................................................52
3.2.7 Microlife ...............................................................................................................52
3.2.8 Vitaphone ............................................................................................................52 3.3 Glucose level monitoring vendors.............................................................................53 3.3.1 Roche ..................................................................................................................53
3.3.2 Johnson & Johnson ............................................................................................54
3.3.3 Abbott Laboratories.............................................................................................55
3.3.4 3.3.5 3.3.6 Bayer Healthcare.................................................................................................55 BodyTel ...............................................................................................................56 Dexcom ...............................................................................................................57
3.3.7 HealthPia America...............................................................................................57
3.3.8 Smith’s Medical ...................................................................................................58
3.4 Lipid monitoring vendors...........................................................................................58 3.4.1 CardioChek .........................................................................................................58 3.4.2 Biomedix..............................................................................................................59 3.5 Other companies .......................................................................................................59 3.5.1 Arrowhead Electronic Healthcare .......................................................................59 3.5.2 iMetrikus ..............................................................................................................60 3.5.3 RTX Healthcare ...................................................................................................60 3.5.4 Viterion TeleHealthcare .......................................................................................60 3.5.5 T+ Medical..........................................................................................................61 4 Telecom and IT industry initiatives ....................................................................................63 4.1 Telecom operators.....................................................................................................63 4.1.1 France Telecom creates Orange Healthcare business unit................................63 4.1.2 Telecom Italia invests in Telbios .........................................................................64 4.1.3 SaskTel first to launch Alcatel-Lucent’s LifeStat .................................................65 4.1.4 Vodafone Spain pilots Aerotel’s e-CliniQ system................................................65 4.1.5 Qualcomm plans Lifecomm health-oriented MVNO ...........................................65 4.1.6 Deutsche Telekom’s T-City project .....................................................................66 4.1.7 NTT DoCoMo introduces health-oriented handsets ...........................................67 4.2 Handset manufacturers .............................................................................................67 4.2.1 Nokia and Apple to make smartphones health applications platforms?............68 4.2.2 LG Electronics to introduce handset with blood pressure meter .......................68 4.3 IT companies .............................................................................................................69 4.3.1 Google Health .....................................................................................................69 4.3.2 Microsoft HealthVault ..........................................................................................70 4.3.3 Intel Health Guide................................................................................................70 4.4 Industry associations.................................................................................................71 4.4.1 Continua Health Alliance.....................................................................................71 4.4.2 The Bluetooth SIG's Medical Working Group .....................................................71 5 Market trends and recommendations ...............................................................................73 5.1 Market analysis..........................................................................................................73 5.2 Market drivers and challenges ..................................................................................75 5.2.1 An aging population............................................................................................75
5.2.2 Increasing welfare disease prevalence ...............................................................76
5.2.3 Focus on disease prevention..............................................................................76
5.2.4 Risks related to alternative treatments ................................................................78
5.3 Potential market catalysts..........................................................................................79
5.3.1 Increased monitoring during clinical trials ..........................................................79
5.3.2 Insurance companies demanding monitoring ....................................................81
5.3.3 Non-prescribed monitoring .................................................................................82
5.4 Recommendations for mobile industry players.........................................................83
Glossary ...................................................................................................................................85

List of Figures
Figure 1.1: Number of people suffering from chronic welfare diseases (EU/US 2008) .............5
Figure 1.2: Percentage of population diagnosed with chronic welfare diseases.......................6
Figure 1.3: Healthcare expenditure per capita by country (US$, World 2005) ........................11
Figure 1.4: Share of population covered by private health insurance by country ...................14
Figure 2.1: Schematic overiview of remote ECG monitoring ...................................................19
Figure 2.2: Example of blood pressure monitor from Omron Healthcare................................21
Figure 2.3: Example of glucose meters from Lifescan and Roche...........................................22
Figure 2.4: Examples of methods for uploading health monitor data......................................26
Figure 3.1: Home medical monitoring market value by segment (World 2007) ......................39
Figure 3.2: Examples of telehealth monitoring equipment for the home .................................61




...